Eton Pharmaceuticals, Inc. (ETON) Stock Surged 9.67% Pre-Market, Here’s Why
Eton Pharmaceuticals, Inc. (ETON) stock soared 9.67% in the pre-market trading session at the price of $4.66 following the FDA approval of cysteine hydrochloride injection. FDA Approved Cysteine HCL Injection On 11th April 2022, ETON announced receiving approval from the U.S. FDA for its cysteine